10940656

Source:http://linkedlifedata.com/resource/pubmed/id/10940656

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0024291, umls-concept:C0030705, umls-concept:C0034845, umls-concept:C0062534, umls-concept:C0229671, umls-concept:C0253023, umls-concept:C0383327, umls-concept:C0441889, umls-concept:C0521115, umls-concept:C0680730, umls-concept:C1148554, umls-concept:C1539477, umls-concept:C1749467, umls-concept:C2826293
pubmed:issue	3
pubmed:dateCreated	2000-9-18
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0141053
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/FASLG protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein, http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transferrin, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:issn	0001-5792
pubmed:author	pubmed-author:KOUSJ CJC, pubmed-author:KamitaniTT, pubmed-author:KinoshitaYY, pubmed-author:KohKK, pubmed-author:KumuraTT, pubmed-author:NishikiSS, pubmed-author:OhtaKK, pubmed-author:TakuboTT, pubmed-author:TatsumiNN, pubmed-author:YamaneTT
pubmed:issnType	Print
pubmed:volume	103
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	165-7
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10940656-Adult, pubmed-meshheading:10940656-Antigens, CD95, pubmed-meshheading:10940656-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10940656-Combined Modality Therapy, pubmed-meshheading:10940656-Cyclophosphamide, pubmed-meshheading:10940656-Doxorubicin, pubmed-meshheading:10940656-Epstein-Barr Virus Infections, pubmed-meshheading:10940656-Fas Ligand Protein, pubmed-meshheading:10940656-Female, pubmed-meshheading:10940656-Hepatocyte Growth Factor, pubmed-meshheading:10940656-Histiocytosis, Non-Langerhans-Cell, pubmed-meshheading:10940656-Humans, pubmed-meshheading:10940656-Interleukin-18, pubmed-meshheading:10940656-Lymphoma, Non-Hodgkin, pubmed-meshheading:10940656-Membrane Glycoproteins, pubmed-meshheading:10940656-Neoplasm Proteins, pubmed-meshheading:10940656-Prednisone, pubmed-meshheading:10940656-Receptors, Transferrin, pubmed-meshheading:10940656-Splenectomy, pubmed-meshheading:10940656-Tumor Virus Infections, pubmed-meshheading:10940656-Vincristine
pubmed:year	2000
pubmed:articleTitle	Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble Fas, soluble Fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome.
pubmed:affiliation	Department of Clinical and Laboratory Medicine, Osaka City University Medical School, Osaka, Japan. m3542254@med.osaka-cu.ac.jp
pubmed:publicationType	Journal Article, Case Reports